(S)-2-(2-aminoethylamino)-N-(3,5-bis(trifluoromethyl)phenethyl)-N-methyl-2-phenylacetamide

ID: ALA3542236

Chembl Id: CHEMBL3542236

PubChem CID: 118753395

Max Phase: Preclinical

Molecular Formula: C21H23F6N3O

Molecular Weight: 447.42

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(CCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)[C@@H](NCCN)c1ccccc1

Standard InChI:  InChI=1S/C21H23F6N3O/c1-30(19(31)18(29-9-8-28)15-5-3-2-4-6-15)10-7-14-11-16(20(22,23)24)13-17(12-14)21(25,26)27/h2-6,11-13,18,29H,7-10,28H2,1H3/t18-/m0/s1

Standard InChI Key:  DMZASYPWXKNYFF-SFHVURJKSA-N

Alternative Forms

  1. Parent:

    ALA3542236

    ---

Associated Targets(non-human)

Liver (4264 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pancreas (215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pituitary (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 447.42Molecular Weight (Monoisotopic): 447.1745AlogP: 4.01#Rotatable Bonds: 8
Polar Surface Area: 58.36Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.09CX LogP: 3.83CX LogD: 2.15
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.60Np Likeness Score: -0.83

References

1. Schadt S, Kallbach S, Almeida R, Sandel J..  (2012)  Investigation of figopitant and its metabolites in rat tissue by combining whole-body autoradiography with liquid extraction surface analysis mass spectrometry.,  40  (3): [PMID:22184457] [10.1124/dmd.111.043562]

Source